{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T04:38:31Z","timestamp":1773635911855,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Our epidemiological study showed that the intestinal flora of Uygur T2DM patients differed from that of normal glucose-tolerant people. However, whether the Uygur T2DM fecal microbiota transplantation could reproduce the glucose metabolism disorder and the mechanism behind has not been reported. This study was designed to explore whether Uygur T2DM fecal microbiota transplantation could reproduce the glucose metabolism disorder and its mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The normal diet and high fat diet group consisted of C57BL\/6 mice orally administered 0.2\u2009mL sterile normal saline. For the MT (microbiota transplantation) intervention groups, C57BL\/6 mice received oral 0.2\u2009mL faecal microorganisms from Uygur T2DM. All mice were treated daily for 8\u2009weeks and Blood glucose levels of mice were detected. Mice faecal DNA samples were sequenced and quantified using 16S rDNA gene sequencing. Then we detected the ability of the intestinal flora to metabolize bile acids (BAs) through co-culture of fecal bacteria and BAs. BA levels in plasma were determined by UPLC-MS. Further BA receptors and glucagon-like peptide-1 (GLP-1) expression levels were determined with RT-q PCR and western blotting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MT impaired insulin and oral glucose tolerance. Deoxycholic acid increased and tauro-\u03b2-muricholic acid and the non-12-OH BA:12-OH BA ratio decreased in plasma. MT improved the ability of intestinal flora to produce deoxycholic acid. Besides, the vitamin D receptor in the liver and ileum and GLP-1 in the ileum decreased significantly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Uygur T2DM fecal microbiota transplantation disrupts glucose metabolism by changing the ability of intestinal flora to metabolize BAs and the BAs\/GLP-1 pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01155-8","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T11:16:14Z","timestamp":1663931774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Uygur type 2 diabetes patient fecal microbiota transplantation disrupts blood glucose and bile acid levels by changing the ability of the intestinal flora to metabolize bile acids in C57BL\/6 mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Chanyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zirun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"1155_CR1","doi-asserted-by":"publisher","first-page":"107842","DOI":"10.1016\/j.diabres.2019.107842","volume":"157","author":"CC Patterson","year":"2019","unstructured":"Patterson CC, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.","journal-title":"Diabetes Res Clin Pract"},{"key":"1155_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ismej.2014.99","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. Isme J. 2015;9:1\u201315.","journal-title":"Isme J"},{"key":"1155_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EC-15-0094","volume":"5","author":"L Egshatyan","year":"2016","unstructured":"Egshatyan L, Kashtanova D, Popenko A, Tkacheva O, Tyakht A, Alexeev D, et al. Gut microbiota and diet in patients with different glucose tolerance. Endocr Connect. 2016;5:1\u20139.","journal-title":"Endocr Connect"},{"key":"1155_CR4","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","volume":"8","author":"Y Gu","year":"2017","unstructured":"Gu Y, Wang X, Li J, Zhang Y, Zhong H, Liu R, et al. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun. 2017;8:1785.","journal-title":"Nat Commun"},{"key":"1155_CR5","doi-asserted-by":"publisher","first-page":"e0172774","DOI":"10.1371\/journal.pone.0172774","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Luo X, Mao X, Tao Y, Ran X, Zhao H, et al. Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks. PLoS One. 2017;12:e0172774.","journal-title":"PLoS One"},{"key":"1155_CR6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/13880209.2021.1954667","volume":"59","author":"X Han","year":"2021","unstructured":"Han X, Wang Y, Zhang P, Zhu M, Li L, Mao X, et al. Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in db\/db mice. Pharm Biol. 2021;59:1077\u201387.","journal-title":"Pharm Biol"},{"key":"1155_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","volume":"32","author":"H Wu","year":"2020","unstructured":"Wu H, Tremaroli V, Schmidt C, Lundqvist A, Olsson LM, Kr\u00e4mer M, et al. The gut microbiota in Prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 2020;32:379\u201390.e3.","journal-title":"Cell Metab"},{"key":"1155_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.micpath.2017.08.038","volume":"111","author":"M Sedighi","year":"2017","unstructured":"Sedighi M, Razavi S, Navab-Moghadam F, Khamseh ME, Alaei-Shahmiri F, Mehrtash A, et al. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog. 2017;111:362\u20139.","journal-title":"Microb Pathog"},{"key":"1155_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11892-018-1057-6","volume":"18","author":"A Sircana","year":"2018","unstructured":"Sircana A, Framarin L, Leone N, Berrutti M, Castellino F, Parente R, et al. Altered gut microbiota in type 2 diabetes: just a coincidence? Curr Diab Rep. 2018;18:98.","journal-title":"Curr Diab Rep"},{"key":"1155_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrneph.2015.191","volume":"12","author":"J Aron-Wisnewsky","year":"2016","unstructured":"Aron-Wisnewsky J, Cl\u00e9ment K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol. 2016;12:169\u201381.","journal-title":"Nat Rev Nephrol"},{"key":"1155_CR11","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00213-019-05265-5","volume":"236","author":"C Gonz\u00e1lez-Arancibia","year":"2019","unstructured":"Gonz\u00e1lez-Arancibia C, Urrutia-Pi\u00f1ones J, Illanes-Gonz\u00e1lez J, Martinez-Pinto J, Sotomayor-Z\u00e1rate R, Julio-Pieper M, et al. Do your gut microbes affect your brain dopamine? Psychopharmacology. 2019;236:1611\u201322.","journal-title":"Psychopharmacology"},{"key":"1155_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3164\/jcbn.18-57","volume":"63","author":"Y Naito","year":"2018","unstructured":"Naito Y, Uchiyama K, Takagi T. A next-generation beneficial microbe: Akkermansia muciniphila. J Clin Biochem Nutr. 2018;63:33\u20135.","journal-title":"J Clin Biochem Nutr"},{"key":"1155_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/s41366-018-0220-0","volume":"43","author":"A Pedret","year":"2019","unstructured":"Pedret A, Valls RM, Calder\u00f3n-P\u00e9rez L, Llaurad\u00f3 E, Companys J, Pla-Pag\u00e0 L, et al. Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial. Int J Obes. 2019;43:1863\u20138.","journal-title":"Int J Obes"},{"key":"1155_CR14","doi-asserted-by":"crossref","unstructured":"Lucas LN, Barrett K, Kerby RL, Zhang Q, Cattaneo LE, Stevenson D, et al. Dominant bacterial phyla from the human gut show widespread ability to transform and conjugate bile acids. mSystems. 2021;6:e00805\u201321.","DOI":"10.1128\/mSystems.00805-21"},{"key":"1155_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ajcn\/nqab232","volume":"114","author":"DA Byrd","year":"2021","unstructured":"Byrd DA, Sinha R, Weinstein SJ, Albanes D, Freedman ND, Sampson J, et al. An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. Am J Clin Nutr. 2021;114:1802\u201313.","journal-title":"Am J Clin Nutr"},{"key":"1155_CR16","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1172\/JCI86674","volume":"126","author":"S Fujisaka","year":"2016","unstructured":"Fujisaka S, Ussar S, Clish C, Devkota S, Dreyfuss JM, Sakaguchi M, et al. Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest. 2016;126:4430\u201343.","journal-title":"J Clin Invest"},{"key":"1155_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12915-017-0462-7","volume":"15","author":"X Zheng","year":"2017","unstructured":"Zheng X, Huang F, Zhao A, Lei S, Zhang Y, Xie G, et al. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice. BMC Biol. 2017;15:120.","journal-title":"BMC Biol"},{"key":"1155_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","volume":"151","author":"FJ Gonzalez","year":"2016","unstructured":"Gonzalez FJ, Jiang C, Patterson AD. An intestinal microbiota-Farnesoid X receptor Axis modulates metabolic disease. Gastroenterology. 2016;151:845\u201359.","journal-title":"Gastroenterology."},{"key":"1155_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","volume":"26","author":"K Wang","year":"2019","unstructured":"Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019;26:222\u201335.e5.","journal-title":"Cell Rep"},{"key":"1155_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.livres.2019.05.001","volume":"3","author":"WM Pandak","year":"2019","unstructured":"Pandak WM, Kakiyama G. The acidic pathway of bile acid synthesis: not just an alternative pathway(\u2606). Liver Res. 2019;3:88\u201398.","journal-title":"Liver Res"},{"key":"1155_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1743-7075-8-48","volume":"8","author":"B Cariou","year":"2011","unstructured":"Cariou B, Chetiveaux M, Za\u00efr Y, Pouteau E, Disse E, Guyomarc'h-Delasalle B, et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults. Nutr Metab (Lond). 2011;8:48.","journal-title":"Nutr Metab (Lond)"},{"key":"1155_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4239\/wjd.v6.i6.850","volume":"6","author":"AT Kharroubi","year":"2015","unstructured":"Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. World J Diabetes. 2015;6:850\u201367.","journal-title":"World J Diabetes"},{"key":"1155_CR23","doi-asserted-by":"publisher","first-page":"e3042","DOI":"10.1002\/dmrr.3042","volume":"34","author":"A Chobot","year":"2018","unstructured":"Chobot A, G\u00f3rowska-Kowolik K, Soko\u0142owska M, Jarosz-Chobot P. Obesity and diabetes-not only a simple link between two epidemics. Diabetes Metab Res Rev. 2018;34:e3042.","journal-title":"Diabetes Metab Res Rev"},{"key":"1155_CR24","doi-asserted-by":"publisher","first-page":"9749","DOI":"10.1038\/s41598-018-28126-1","volume":"8","author":"BA Peters","year":"2018","unstructured":"Peters BA, Shapiro JA, Church TR, Miller G, Trinh-Shevrin C, Yuen E, et al. A taxonomic signature of obesity in a large study of American adults. Sci Rep. 2018;8:9749.","journal-title":"Sci Rep"},{"key":"1155_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson FH, Tremaroli V, Nookaew I, Bergstr\u00f6m G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99\u2013103.","journal-title":"Nature."},{"key":"1155_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gutjnl-2018-316103","volume":"68","author":"J Aron-Wisnewsky","year":"2019","unstructured":"Aron-Wisnewsky J, Prifti E, Belda E, Ichou F, Kayser BD, Dao MC, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68:70\u201382.","journal-title":"Gut."},{"key":"1155_CR27","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022\u20133.","journal-title":"Nature."},{"key":"1155_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4161\/gmic.21216","volume":"3","author":"A Yokota","year":"2012","unstructured":"Yokota A, Fukiya S, Islam KB, Ooka T, Ogura Y, Hayashi T, et al. Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes. 2012;3:455\u20139.","journal-title":"Gut Microbes"},{"key":"1155_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1053\/j.gastro.2009.08.042","volume":"137","author":"MA Hildebrandt","year":"2009","unstructured":"Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1716\u201324.e1\u20132.","journal-title":"Gastroenterology."},{"key":"1155_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cmet.2015.02.004","volume":"21","author":"P Li","year":"2015","unstructured":"Li P, Ruan X, Yang L, Kiesewetter K, Zhao Y, Luo H, et al. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metab. 2015;21:455\u201367.","journal-title":"Cell Metab"},{"key":"1155_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","volume":"12","author":"W Jia","year":"2021","unstructured":"Jia W, Wei M, Rajani C, Zheng X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2021;12:411\u201325.","journal-title":"Protein Cell"},{"key":"1155_CR32","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.2337\/db13-0639","volume":"62","author":"RA Haeusler","year":"2013","unstructured":"Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids. Diabetes. 2013;62:4184\u201391.","journal-title":"Diabetes."},{"key":"1155_CR33","doi-asserted-by":"publisher","first-page":"108212","DOI":"10.1016\/j.celrep.2020.108212","volume":"33","author":"L Chen","year":"2020","unstructured":"Chen L, van den Munckhof ICL, Schraa K, Ter Horst R, Koehorst M, van Faassen M, et al. Genetic and microbial associations to plasma and fecal bile acids in obesity relate to plasma lipids and liver fat content. Cell Rep. 2020;33:108212.","journal-title":"Cell Rep"},{"key":"1155_CR34","doi-asserted-by":"publisher","first-page":"102766","DOI":"10.1016\/j.ebiom.2020.102766","volume":"55","author":"M Wei","year":"2020","unstructured":"Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. 2020;55:102766.","journal-title":"EBioMedicine."},{"key":"1155_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, J\u00e4ntti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17:225\u201335.","journal-title":"Cell Metab"},{"key":"1155_CR36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.apsb.2019.02.004","volume":"9","author":"L Sun","year":"2019","unstructured":"Sun L, Pang Y, Wang X, Wu Q, Liu H, Liu B, et al. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B. 2019;9:702\u201310.","journal-title":"Acta Pharm Sin B"},{"key":"1155_CR37","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018;24:1919\u201329.","journal-title":"Nat Med"},{"key":"1155_CR38","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11:5015.","journal-title":"Nat Commun"},{"key":"1155_CR39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1053\/j.gastro.2018.11.017","volume":"156","author":"VL Albaugh","year":"2019","unstructured":"Albaugh VL, Banan B, Antoun J, Xiong Y, Guo Y, Ping J, et al. Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery. Gastroenterology. 2019;156:1041\u201351.","journal-title":"Gastroenterology."}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01155-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T11:19:33Z","timestamp":1663931973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01155-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01155-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"1 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of human subjects and the C57BL\/6 mice was sanctioned by Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Urumqi, China; approval No: 20140212\u2013113) and performed according to the Declaration of Helsinki. all methods were carried out in accordance with relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines. Prior to sample collection, informed consent (written) was obtained from the donor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no conflict of interest to report regarding the work presented in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}